Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Specific ppar excitant for treating negative energy equilibrium

An energy balance, ruminant technology, applied in applications, animal feed, animal feed, etc., can solve the problems of complex interaction, limited knowledge, and lack of understanding of PPAR expression, yield or quality.

Inactive Publication Date: 2007-05-02
PFIZER PRODS ETAT DE CONNECTICUT
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, as stated, the interplay of biological processes is complex and knowledge of the important genes, enzymes and endogenous substrates required to optimize energy balance in transition cows is limited
Furthermore, it is not known how much altering PPAR expression can affect yield or quality, lipolysis or gluconeogenesis, since NEFA’s are key substrates for milk and glucose biosynthesis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Specific ppar excitant for treating negative energy equilibrium
  • Specific ppar excitant for treating negative energy equilibrium
  • Specific ppar excitant for treating negative energy equilibrium

Examples

Experimental program
Comparison scheme
Effect test

preparation Embodiment

[0244] In the following formulations, "active ingredient" refers to the compound used in the present invention.

[0245] Formulation 1: Solution for parenteral administration

[0246] components

Amount (mg / 5ml)

active ingredient

Potassium hydroxide

sodium hydroxide

Sodium dihydrogen phosphate

Disodium phosphate

pvp

Methylparaben

water

1-750

0-75

0-75

0-50

0-100

0-50

0-40

Up to 5ml

[0247] or

[0248] Formulation 2: Solution for parenteral administration

[0249] components

Amount (mg / 5ml)

active ingredient

Sodium dihydrogen phosphate

Disodium phosphate

Methylparaben

water

1-750

0-50

0-100

0-40

Up to 5ml

[0250] or

[0251] Formulation 3: Solution for parenteral administration

[0252] components

Amount (mg / 5ml)

active ingredient

Hydroxypropyl beta-cyclodextrin

Methy...

Embodiment 12

[0270] Example 12-: (3-{1-[(4-isopropyl-phenyl)-acetyl]-piperidin-3-yl}-phenoxy)-2-methyl-propionic acid benzyl ester

Embodiment 1-12

[0271] Example 1-12-: (3-{1-[(3-methoxy-phenyl)-acetyl]-piperidin-3-yl}-phenoxy)-2-methyl-propionic acid

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The use of a compound of formula (I): an isomer thereof, a prodrug of said compound or isomer, or a pharmaceutically acceptable salt of said compound, isomer or prodrug, in the manufacture of a medicament for the palliative, prophylactic or curative treatment of negative energy balance in ruminants. The use of a compound of formula (I), in the manufacture of a medicament for the palliative, prophylactic or curative treatment of ruminant disease associated with negative energy balance in ruminants, wherein, preferably, the ruminant disease associated with negative energy balance in ruminants is selected from fatty liver syndrome, dystocia, immune dysfunction, impaired immune function, toxification, primary ketosis, secondary ketosis, downer cow syndrome, indigestion, inappetence, retained placenta, displaced abomasum, mastitis, (endo-)-metritis, infertility, low fertility, and lameness.

Description

field of invention [0001] The invention described herein relates to the use of peroxisome proliferator-activated receptor (PPAR) agonists, in particular PPARα agonists, in the treatment of negative energy balance in ruminants, and more particularly, in combination with Applications in Negative Energy Balance (NEB)-Related Diseases in Ruminants. Background of the invention [0002] The ruminant transition period is defined as the period spanning gestation to early lactation. It is sometimes defined as from prepartum to 3 weeks postpartum, but has been extended from 30 days prepartum to 70 days postpartum (J N Spain and W A Scheer, Tri-State Dairy Nutrition Conference, 2001, 13). [0003] Energy balance was defined as energy intake minus energy output, and animals were described as having negative energy balance if energy intake was insufficient to meet requirements for maintenance and production (eg milk). Cows in the NEB must find energy that is missing from their body res...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/451A61K31/454A61P3/00A61P1/16A61P1/00A61P15/14A61P15/08A61P37/00A23K1/16A23K1/18A23K50/15
CPCA61K31/454A61K31/451A61P1/00A61P1/14A61P1/16A61P15/08A61P15/14A61P3/00A61P3/06A61P37/00A61P43/00
Inventor M·E·小凯尔利
Owner PFIZER PRODS ETAT DE CONNECTICUT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products